The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The proposed facility is expected to be operational around January, 2027
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
Additional capacity broadens Grace’s fine chemical capabilities for API production
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Subscribe To Our Newsletter & Stay Updated
